phrykt

Vertex Pharmaceuticals Inc / Ma (VRTX) revenue: $12B

Vertex Pharmaceuticals Inc / Ma reported $12B of revenue for the year ended Dec 31, 2025, up 8.9% from $11B a year earlier.

From Vertex Pharmaceuticals Inc / Ma's filings with the SEC · Read the filing · VRTX stock page

Vertex Pharmaceuticals Inc / Ma revenue by year

$7.6B2021$8.9B2022$9.9B2023$11B2024$12B2025

#384 of 3,623 US companies by revenue · See the full ranking

Year endedRevenueChange
Dec 31, 2025$12B+9%
Dec 31, 2024$11B+12%
Dec 31, 2023$9.9B+11%
Dec 31, 2022$8.9B+18%
Dec 31, 2021$7.6B–

Revenue of similar companies

Companies in the same industry as Vertex Pharmaceuticals Inc / Ma, by SEC industry code, with the closest revenue. Each name opens the same page for that company.

CompanyRevenue, latest yearYear ended
TEVA Pharmaceutical Industries$17.3BDec 31, 2025
Regeneron Pharmaceuticals$14.3BDec 31, 2025
Viatris$14.3BDec 31, 2025
Vertex Pharmaceuticals Inc / Ma$12BDec 31, 2025
Bausch Health Companies$10.3BDec 31, 2025
Zoetis$9.5BDec 31, 2025
Organon$6.2BDec 31, 2025

Questions and answers

What is Vertex Pharmaceuticals Inc / Ma's revenue?

Vertex Pharmaceuticals Inc / Ma reported $12B of revenue for the year ended Dec 31, 2025, up 8.9% from $11B a year earlier.

Numbers as reported in Vertex Pharmaceuticals Inc / Ma's annual and quarterly reports to the SEC (XBRL data). A year is the company's fiscal year that falls mostly in that calendar year; balances such as cash and debt are as of the date shown. Data only, not investment advice. Methodology